Stock Movers

Today's biggest gainers and decliners in the stock market.
On this episode of Stock Movers:
- Shopify (SHOP) shares are trading higher in trading today, extending Monday’s gains after Chief Executive Officer Tobi Lutke announced on the social media platform X that the e-commerce firm was “partnering deeply” with Meta Platforms’ Muse artificial intelligence agent.
- Morderna (MRNA) shares are also extending gains for a second day, to hit its highest intraday level since 2023. The biotech previously reported on Monday that it will present data on its personalized cancer vaccine in October.
- On (ONON) expects sales growth in the high teens over the next few years as the Swiss sneaker brand moves into sports including golf and football to take on the likes of Adidas and Nike. Backed by tennis legend Roger Federer, On has grown rapidly since its 2010 founding, starting with running shoes and expanding into tennis, training and outdoor sports. A 10-year partnership with French superstar Kylian Mbappé breaks new ground for On in football, long dominated by its bigger rivals. The stock rallied as much as 14% in New York, the most intraday since November.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Viking Therapeutics (VKTX) shares surged after its dual-action obesity shot helped patients lose weight and keep it off, even after they cut their dosing schedule in a small, exploratory study.
- On Holding (ONON) shares jump after the Swiss sneaker maker provided its three-year financial plan ahead of its Investor Day in Zurich, Switzerland. Management also declared a buyback plan of up to $1 billion of its Class A shares through the end of 2029. It reaffirmed its annual outlook and projected 3Q sales growth up ~17% in constant currency (CC) vs mid-to-high-teens prior.
- Quest Diagnostics (DGX) shares fall most intraday since 2022, after the Centers for Medicare & Medicaid Services (CMS) released new preliminary medicare payment rates for lab services.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Alibaba (BABA) shares are higher this morning after the company rolled out what it calls China’s most powerful AI chip and announced plans to expand data center capacity in the coming years.
- ON Holdings (ONON) is getting a boost as it expects sales growth in the high teens over the next few years as it moves into sports including golf and football.
- Viking Therapeutics (VKTX) shares surged after the biotech released data from its VK2735-102 maintenance study showing VK2735, its experimental obesity drug, maintained up to 97% of weight loss versus 61% for placebo when subjects switched to every-other-week dosing. Leerink analysts said the “stellar” data strengthens the drug’s competitive profile.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Alibaba (BABA) shares are higher this morning after the company rolled out what it calls China’s most powerful AI chip and announced plans to expand data center capacity in the coming years.
- ON Holdings (ONON) is getting a boost as it expects sales growth in the high teens over the next few years as it moves into sports including golf and football.
- Quest Diagnostics (DGX) is sliding after the Centers for Medicare & Medicaid Services (CMS) released new preliminary medicare payment rates for lab services.
- GameStop (GME) is rising after CEO Ryan Cohen reported an insider stock transaction to the US Securities and Exchange Commission.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Kingfisher shares rise as much as 11%, the most in a year, after the B&Q and Screwfix owner posted a first-half earnings beat and lifted its full-year profit guidance beyond analyst expectations.
- Roche Holding’s experimental obesity shot enicepatide cut both blood sugar and body weight in type-2 diabetes patients who were overweight or obese in a mid-stage trial.
- Ericsson slips as much as 3.9%, the most since mid July, after Morgan Stanley downgrades the Swedish mobile networks and technology group to underweight from equal-weight, saying margins are “inflecting to the downside.”
See omnystudio.com/listener for privacy information.